Caudal Regression Syndrome
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Sacral agenesis
|
0.700 |
SusceptibilityMutation
|
disease |
ORPHANET |
Mutations in VANGL1 associated with neural-tube defects.
|
17409324 |
2007 |
Caudal Regression Syndrome
|
0.600 |
SusceptibilityMutation
|
disease |
ORPHANET |
Mutations in VANGL1 associated with neural-tube defects.
|
17409324 |
2007 |
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO
|
0.600 |
SusceptibilityMutation
|
disease |
CLINVAR |
|
|
|
Sacral Agenesis Syndrome
|
0.300 |
SusceptibilityMutation
|
phenotype |
ORPHANET |
Mutations in VANGL1 associated with neural-tube defects.
|
17409324 |
2007 |
Spina bifida aperta of cervical spine
|
0.300 |
SusceptibilityMutation
|
disease |
ORPHANET |
Novel mutations in VANGL1 in neural tube defects.
|
19319979 |
2009 |
Spina bifida aperta of cervical spine
|
0.300 |
SusceptibilityMutation
|
disease |
ORPHANET |
Mutations in VANGL1 associated with neural-tube defects.
|
17409324 |
2007 |
Caudal dysplasia syndrome
|
0.300 |
SusceptibilityMutation
|
disease |
ORPHANET |
Mutations in VANGL1 associated with neural-tube defects.
|
17409324 |
2007 |
Tumor Cell Invasion
|
0.080 |
AlteredExpression
|
phenotype |
BEFREE |
Here, through bioinformatic analyses and functional studies, we showed that miR-124, miR-27a, and miR-30b negatively regulate KITENIN expression and suppress the migration and invasion of several CRC cell lines via modulation of KITENIN expression.
|
24909917 |
2014 |
Tumor Cell Invasion
|
0.080 |
AlteredExpression
|
phenotype |
BEFREE |
Thus, antitumor effects of KITENIN siRNA derives from both the generation of a tumor-specific immune response in vivo through increased 90K secretion from tumor cells and the suppression of tumor invasion in which PKCI is related to increased invasiveness.
|
16204073 |
2005 |
Tumor Cell Invasion
|
0.080 |
AlteredExpression
|
phenotype |
BEFREE |
Through repressing miR-605-3p availability, circ-VANGL1 contributes to VANGL1 expression, consequently leading to BC cell proliferation, migration, and invasion.
|
30146736 |
2019 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
In addition, tumor tissues from metastatic patients with colorectal cancer who showed initial poor responses to cetuximab/chemotherapy expressed higher levels of KITENIN than did responders to therapy.
|
24893630 |
2014 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
On the other hand, STB1 and STB2 are significantly down-regulated in several cancer cell lines and primary tumors.
|
12060845 |
2002 |
Neoplasms
|
0.070 |
AlteredExpression
|
group |
BEFREE |
In a preliminary clinical study using resected tissues from head and neck SCC patients, KITENIN was highly expressed in tumors and metastatic lymph nodes, while KAI1 was more increased in adjacent mucosa than in tumor.
|
19166844 |
2009 |
Colorectal Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Biological alterations following EGF treatment were identified in KITENIN-overexpressed colorectal cancer cells with or without alteration of EGFR activity.
|
24893630 |
2014 |
Colorectal Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Thus, KITENIN functions in the maintenance of a higher expression level of ErbB4 in advanced CRC tissues, independent of ubiquitin-mediated degradation via Nrdp1.
|
27648936 |
2017 |
Colorectal Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the mRNA expression of KITENIN and that of ErbB4-CYT-2 were positively correlated in human colorectal cancer tissue.
|
26527747 |
2016 |
Malignant Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
On the other hand, STB1 and STB2 are significantly down-regulated in several cancer cell lines and primary tumors.
|
12060845 |
2002 |
Primary malignant neoplasm
|
0.050 |
AlteredExpression
|
group |
BEFREE |
On the other hand, STB1 and STB2 are significantly down-regulated in several cancer cell lines and primary tumors.
|
12060845 |
2002 |
Malignant neoplasm of colon and/or rectum
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the mRNA expression of KITENIN and that of ErbB4-CYT-2 were positively correlated in human colorectal cancer tissue.
|
26527747 |
2016 |
Malignant neoplasm of colon and/or rectum
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
KITENIN functions as a fine regulator of ErbB4 expression level in colorectal cancer via protection of ErbB4 from E3-ligase Nrdp1-mediated degradation.
|
27648936 |
2017 |
Malignant neoplasm of colon and/or rectum
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Biological alterations following EGF treatment were identified in KITENIN-overexpressed colorectal cancer cells with or without alteration of EGFR activity.
|
24893630 |
2014 |
Liver carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
We silenced VANGL1 gene expression in the HepG2 HCC cell line by stable transfection with a vector containing siRNA template for VANGL1 and investigated the change in cell invasion and motility.
|
25874746 |
2015 |
Liver carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
To functionally characterize KITENIN in human HCC, we depleted its expression in human HCC cell lines, HepG2 and Huh7, by using small interfering RNA (siRNA).
|
21473287 |
2011 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
STB2 is highly expressed in MKN28, MKN74 (gastric cancer), BxPC-3, PSN-1, and Hs766T (pancreatic cancer) cells.
|
12060845 |
2002 |